-
Je něco špatně v tomto záznamu ?
Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity
E. Parobkova, J. van der Zee, L. Dillen, C. Van Broeckhoven, R. Rusina, R. Matej,
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2010
Free Medical Journals
od 2010
PubMed Central
od 2010
Europe PubMed Central
od 2010
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2010-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2010
- Publikační typ
- časopisecké články MeSH
Background: Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common type of a group of transmissible spongiform encephalopathies (prion diseases). The etiology of the sporadic form of CJD is still unclear. sCJD can occur in combination with other neurodegenerative diseases, which further complicates the diagnosis. Alzheimer's disease (AD), e.g., is often seen in conjunction with sCJD. Method: In this study, we performed a systematic analysis of 15 genes related to the most important neurodegenerative diseases - AD, frontotemporal dementia, amyotrophic lateral sclerosis, prion disease, and Parkinson's disease - in a cohort of sCJD and sCJD in comorbidity with AD and primary age-related proteinopathy (PART). A total of 30 neuropathologically verified cases of sCJD with and without additional proteinopathies were included in the study. In addition, we compared microtubule-associated protein tau (MAPT) haplotypes between sCJD patients and patients with sCJD and PART or sCJD and AD. Then we studied the interaction between the Apolipoprotein E gene (APOE) and PRNP in sCJD patients. Results: We did not find any causal mutations in the neurodegenerative disease genes. We did detect a p.E318G missense variant of uncertain significance (VUS) in PSEN1 in three patients. In PRNP, we also found a previously described non-pathogenic insertion (p.P84_Q91Q). Conclusion: Our pilot study failed to find any critical differences between pure sCJD and sCJD in conjunction with other comorbid neurodegenerative diseases. Further investigations are needed to better understand this phenomenon.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21001643
- 003
- CZ-PrNML
- 005
- 20210126092809.0
- 007
- ta
- 008
- 210105s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3389/fneur.2020.596108 $2 doi
- 035 __
- $a (PubMed)33329348
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Parobkova, Eva $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czechia. National Reference Laboratory for Human Prion Diseases, Thomayer Hospital, Prague, Czechia.
- 245 10
- $a Sporadic Creutzfeldt-Jakob Disease and Other Proteinopathies in Comorbidity. / $c E. Parobkova, J. van der Zee, L. Dillen, C. Van Broeckhoven, R. Rusina, R. Matej,
- 520 9_
- $a Background: Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common type of a group of transmissible spongiform encephalopathies (prion diseases). The etiology of the sporadic form of CJD is still unclear. sCJD can occur in combination with other neurodegenerative diseases, which further complicates the diagnosis. Alzheimer's disease (AD), e.g., is often seen in conjunction with sCJD. Method: In this study, we performed a systematic analysis of 15 genes related to the most important neurodegenerative diseases - AD, frontotemporal dementia, amyotrophic lateral sclerosis, prion disease, and Parkinson's disease - in a cohort of sCJD and sCJD in comorbidity with AD and primary age-related proteinopathy (PART). A total of 30 neuropathologically verified cases of sCJD with and without additional proteinopathies were included in the study. In addition, we compared microtubule-associated protein tau (MAPT) haplotypes between sCJD patients and patients with sCJD and PART or sCJD and AD. Then we studied the interaction between the Apolipoprotein E gene (APOE) and PRNP in sCJD patients. Results: We did not find any causal mutations in the neurodegenerative disease genes. We did detect a p.E318G missense variant of uncertain significance (VUS) in PSEN1 in three patients. In PRNP, we also found a previously described non-pathogenic insertion (p.P84_Q91Q). Conclusion: Our pilot study failed to find any critical differences between pure sCJD and sCJD in conjunction with other comorbid neurodegenerative diseases. Further investigations are needed to better understand this phenomenon.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a van der Zee, Julie $u Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Vlaams Instituut voor Biotechnologie (VIB), Antwerp, Belgium. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Dillen, Lubina $u Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Vlaams Instituut voor Biotechnologie (VIB), Antwerp, Belgium. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Van Broeckhoven, Christine $u Neurodegenerative Brain Diseases Group, VIB Center for Molecular Neurology, Vlaams Instituut voor Biotechnologie (VIB), Antwerp, Belgium. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium.
- 700 1_
- $a Rusina, Robert $u National Reference Laboratory for Human Prion Diseases, Thomayer Hospital, Prague, Czechia. Department of Neurology, Third Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czechia.
- 700 1_
- $a Matej, Radoslav $u Department of Pathology and Molecular Medicine, Third Faculty of Medicine, Charles University and Thomayer Hospital, Prague, Czechia. National Reference Laboratory for Human Prion Diseases, Thomayer Hospital, Prague, Czechia. Department of Pathology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czechia. Department of Pathology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czechia.
- 773 0_
- $w MED00174552 $t Frontiers in neurology $x 1664-2295 $g Roč. 11, č. - (2020), s. 596108
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33329348 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210126092805 $b ABA008
- 999 __
- $a ind $b bmc $g 1613962 $s 1121927
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 11 $c - $d 596108 $e 20201130 $i 1664-2295 $m Frontiers in neurology $n Front. neurol. $x MED00174552
- LZP __
- $a Pubmed-20210105